A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Cubit Diagnostics announced on Tuesday that it has been awarded $2.6 million by the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) Tech program. The funding will enable the ...

The United States is seeing a second peak in flu cases this season. After doctor’s office visits for flu dipped early this ...

According to the province's respiratory illness surveillance report COVID-19 test positivity continues to decline. Influenza ...

A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

Thousands of men in Yorkshire will be offered the opportunity to take part in a new £4.5 million prostate screening trial led ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

Exchange Traded Concepts LLC bought a new position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR – Free Report) during the fourth quarter, according to its most recent 13F filing with the ...

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.